PSMAcTION: A phase II/III, open-label, international, multicenter, randomized study of AAA817 versus standard of care in the treatment of adult participants with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu-PSMA targeted therapy.

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT06780670

Study #:
STUDY00162040

Start Date:
Dec 16, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06780670

View Complete Trial Details & Eligibility at ClinicalTrials.gov